Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung
出版年份 2013 全文链接
标题
Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung
作者
关键词
Non-small cell lung cancer, Adenocarcinomas, Squamous cell carcinomas, Immunohistochemistry techniques, Squamous cell lung carcinoma, Endothelial cells, Lung and intrathoracic tumors, Carcinomas
出版物
PLoS One
Volume 8, Issue 11, Pages e80292
出版商
Public Library of Science (PLoS)
发表日期
2013-11-15
DOI
10.1371/journal.pone.0080292
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma
- (2012) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
- (2012) Jason Hanna et al. BIOTECHNIQUES
- Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells
- (2012) Christopher R. Zito et al. PLoS One
- VEGFR-2 expression in human melanoma: Revised assessment
- (2011) Kerrington R. Molhoek et al. INTERNATIONAL JOURNAL OF CANCER
- Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
- (2011) Natasha Rekhtman et al. MODERN PATHOLOGY
- VEGFR2 Translocates to the Nucleus to Regulate Its Own Transcription
- (2011) Inês Domingues et al. PLoS One
- Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
- (2011) J. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody validation
- (2010) Jennifer Bordeaux et al. BIOTECHNIQUES
- Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
- (2010) N. R. Smith et al. CLINICAL CANCER RESEARCH
- Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells
- (2010) Sirin A I Adham et al. LABORATORY INVESTIGATION
- Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens
- (2010) F. Grossi et al. ONCOLOGIST
- Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer
- (2009) Enrique Carrillo de Santa Pau et al. CANCER
- High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma
- (2009) V. K. Anagnostou et al. CLINICAL CANCER RESEARCH
- Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
- (2009) F. Grossi et al. ONCOLOGIST
- High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer
- (2008) Sriparna Ghosh et al. HUMAN PATHOLOGY
- Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis
- (2008) Ifat Sher et al. INTERNATIONAL JOURNAL OF CANCER
- Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma
- (2008) Valsamo K. Anagnostou et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started